Christopher R. Fenimore - 16 Dec 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
16 Dec 2022
Transactions value $
$0
Form type
4
Filing time
20 Dec 2022, 15:06:42 UTC
Previous filing
13 Dec 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +1.93K +11.56% $0.00 18.6K 16 Dec 2022 Direct F1
holding REGN Common Stock 1.78K 16 Dec 2022 2021 GRAT
holding REGN Common Stock 5K 16 Dec 2022 2022 GRAT
holding REGN Common Stock 1.48K 16 Dec 2022 By 401(k) Plan
holding REGN Common Stock 1.9K 16 Dec 2022 By Trust F2
holding REGN Common Stock 461 16 Dec 2022 by Trust for Daugh
holding REGN Common Stock 460 16 Dec 2022 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +7.11K $0.00 7.11K 16 Dec 2022 Common Stock 7.11K $726.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.
F2 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
F3 The stock option award vests in four equal annual installments, commencing one year after the date of grant.